MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors

Cancer Cell

Volumn 6, Issue 6, 2004, Pages 587-596

  Huntly, Brian J P ^a   Shigematsu, Hirokazu ^b   Deguchi, Kenji ^a   Lee, Benjamin H ^a   Mizuno, Shinichi ^b   Duclos, Nicky ^a   Rowan, Rebecca ^a   Amaral, Sonia ^a   Curley, David ^a   Williams, Ifor R ^c   Akashi, Koichi ^b   Gilliland, D Gary ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; METHYLCELLULOSE; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN MOZ; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL RENEWAL; CONTROLLED STUDY; GENETIC TRANSDUCTION; GRANULOCYTE; HEMATOPOIETIC CELL; LEUKEMIA CELL; LIQUID CULTURE; MONOCYTE; MOUSE; MUTATIONAL ANALYSIS; MYELOID PROGENITOR CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

ANIMALIA; MURINAE;

EID: 19944385935     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.10.015     Document Type: Article

References (43)

1. Akashi K., Traver D., Miyamoto T., Weissman I. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:1999;193-197
2. Alcalay M., Meani N., Gelmetti V., Fantozzi A., Fagioli M., Orleth A., Riganelli D., Sebastiani C., Cappelli E., Casciari C., et al. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J. Clin. Invest. 112:2003;1751-1761
3. Al-Hajj M., Wicha M., Benito-Hernandez A., Morrison S., Clarke M. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA. 100:2003;3983-3988
4. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3:1997;730-737
5. Borrow J., Stanton V.P., Andresen J.M., Becher R., Behm F.G., Chaganti R., Civin C., Disteche C., Dube I., Frischauf A., et al. The translocation t(8;16) (p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat. Genet. 14:1996;33-41
6. Bradford G., Williams B., Rossi R., Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp. Hematol. 25:1997;445-453
7. Carapeti M., Aguiar R., Goldman J., Cross N. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood. 91:1988;3127-3133
8. Chesier S., Morrison S., Liao X., Weissman I. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. USA. 96:1999;3120-3125
9. Cobaleda C., Guitierrez-Cianca N., Perez-Losada J., Flores T., Garcia-Sanz R., Gonzalez M., Sanchez-Garcia I. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood. 95:2000;1007-1013
10. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17:2003;3029-3035
11. Dash A., Williams I., Kutok J., Tomasson M., Anastasiadou E., Lindahl K., Li S., Van Etten R., Borrow J., Housman D., et al. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Proc. Natl. Acad. Sci. USA. 99:2002;7622-7627
12. de Guzman C.G., Warren A.J., Zhang Z., Gartland L., Erickson P., Drabkin H., Hiebert S.W., Klug C.A. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. Mol. Cell. Biol. 22:2002;5506-5517
13. Deguchi K., Ayton P., Carapeti M., Kutok J., Snyder C., Williams I., Cross N., Glass C., Cleary M., Gilliland D. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell. 3:2003;259-271
14. Deininger M., Goldman J., Melo J. The molecular biology of chronic myeloid leukemia. Blood. 96:2000;3343-3356
15. Fialkow P., Singer J., Adamson J., Vaidya K., Dow L., Ochs J., Moohr J. Acute nonlymphocytic leukemia. heterogeneity of stem cell origin Blood. 57:1981;1068-1073
16. Graham S.M., Jorgensen H.G., Allan E., Pearson C., Alcorn M.J., Richmond L., Holyoake T.L. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 99:2002;319-325
17. Griffin J., Lowenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood. 68:1986;1185-1195
18. Haase D., Feuring-Buske M., Konemann S., Fonatsch C., Troff C., Verbeek W., Pekrun A., Hiddemann W., Wormann B. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood. 86:1995;2906-2912
19. Hanahan D., Weinberg R. The hallmarks of cancer. Cell. 100:2000;57-70
20. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA. 100:2003;15178-15183
21. Higuchi M., O'Brien D., Kumaravelu P., Lenny N., Yeoh E.J., Downing J.R. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell. 1:2002;63-74
22. Hope K., Jin L., Dick J. Acute myeloid leukemia originates from a hierarchy of leukemic stem cells classes that differ in self-renewal capacity. Nat. Immunol. 5:2004;738-743
23. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia. 39:2002;193-206
24. Lansdorp P. Self-renewal of stem cells. Biol. Blood Marrow Transplant. 3:1997;171-178
25. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 367:1994;645-648
26. Lavau C., Szilvassy S.J., Slany R., Cleary M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16:1997;4226-4237
27. Lessard J., Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:2003;255-260
28. Manz M.G., Miyamoto T., Akashi K., Weissman I.L. Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl. Acad. Sci. USA. 99:2002;11872-11877
29. Martin P.J., Najfeld V., Hansen J.A., Penfold G.K., Jacobson R.J., Fialkow P.J. Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature. 287:1980;49-50
30. Mehrotra B., George T., Kavanau K., Avet-Loiseau H., Moore D.N., Willman C., Slovak M., Atwater S., Head D., Pallavicini M. Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood. 86:1995;1139-1147
31. Melo, J.V., Hughes, T.P., and Apperley, J.F. (2003). Chronic myeloid leukemia. Hematology (Am. Soc. Hematol. Educ. Program) 2003, 132-152.
32. Morrison S., Prowse K., Ho P., Weissman I. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity. 5:1996;207-216
33. Muller-Tidow C., Steffen B., Cauvet T., Tickenbrock L., Ji P., Diedrichs S., Sargin B., Kohler G., Stelljes M., Puccetti E., et al. Translocation products in acute myeloid leukemia activate the Wnt signalling pathway in hematopoietic cells. Mol. Cell. Biol. 24:2004;2890-2903
34. Mulloy J.C., Cammenga J., MacKenzie K.L., Berguido F.J., Moore M.A., Nimer S.D. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood. 99:2002;15-23
35. Mulloy J.C., Cammenga J., Berguido F.J., Wu K., Zhou P., Comenzo R.L., Jhanwar S., Moore M.A., Nimer S.D. Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. Blood. 102:2003;4369-4376
36. Na Nakorn T., Traver D., Weissman I., Akashi K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J. Clin. Invest. 109:2002;1579-1585
37. Quijano C., Moore D.N., Arthur D., Feusner J., Winter S., Pallavicini M. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia. Leukemia. 11:1997;1508-1515
38. Reya T., Morrison S., Clarke M., Weissman I. Stem cells, cancer, and cancer stem cells. Nature. 414:2001;105-111
39. Rhoades K.L., Hetherington C.J., Harakawa N., Yergeau D.A., Zhou L., Liu L.Q., Little M.T., Tenen D.G., Zhang D.E. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. Blood. 96:2000;2108-2115
40. Sattler M., Griffin J.D. Molecular mechanisms of transformation by the BCR-ABL oncogene. Semin. Hematol. 40:2003;4-10
41. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63:2003;5821-5828
42. Tonks A., Pearn L., Tonks A.J., Pearce L., Hoy T., Phillips S., Fisher J., Downing J.R., Burnett A.K., Darley R.L. The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells. Blood. 101:2003;624-632
43. Wong S., Witte O. Modeling Philadelphia chromosome positive leukemias. Oncogene. 20:2001;5644-5659